Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?

INTRODUCTION: Interstitial lung disease (ILD) is a frequent extra-articular manifestation of Rheumatoid arthritis (RA), but nowadays there are no randomized controlled clinical trials to support therapeutic guidelines. RA-ILD, especially with UIP pattern, shares some similarities with idiopathic pul...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Respir Med Case Rep
Main Authors: Cassone, Giulia, Sebastiani, Marco, Vacchi, Caterina, Cerri, Stefania, Salvarani, Carlo, Manfredi, Andreina
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2020
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7150508/
https://ncbi.nlm.nih.gov/pubmed/32292694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2020.101051
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki